Skip to content

Tipranavir enters phase III trials

Think HIV: Routine HIV screening programme captures undiagnosed infections

HIV transmission rate ten times higher during primary infection

Alpha interferon makes a comeback as HIV treatment

ddI dosing with tenofovir defined

Generic nevirapine: quality control reports show good results

Here come the hi-tech microbicides

Anti-TB and HIV drugs work well together say studies

Clinton tells Boston conference of AIDS threat to world democracy

CD4-guided treatment interruption reduces time on therapy by two-thirds

Counting the cost of late presentation for HIV care

All immigrants to UK may be tested for HIV

HIV superinfection: more evidence

NAM Tuberculosis information forum summary online now

Single class therapy may be enough to control HIV in some drug-resistant patients

2NN study shows nevirapine equal to efavirenz, but has better lipid profile

Additional case reports of tenofovir kidney toxicity

Cardiovascular risks of HAART: More data but little more clarity?